title: Ruxolitinib and DNA methyltransferase-inhibitors: a foray into combination regimens in myelofibrosis.
authors.affiliation: Department of Leukemia, M. D. Anderson Cancer Center , Houston, TX , USA.
authors.forename: Naval
authors.initials: N
authors.lastname: Daver
authors.forename: Srdan
authors.initials: S
authors.lastname: Verstovsek
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D055728:Primary Myelofibrosis / Q000188:drug therapy*